முதல் ஆசிரிய News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முதல் ஆசிரிய. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முதல் ஆசிரிய Today - Breaking & Trending Today

Държавата на „Слънцето"

Държавата на „Слънцето"
frognews.bg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frognews.bg Daily Mail and Mail on Sunday newspapers.

Sofiya Grad , Bruxelles Capitale , Boyko Rashkov , Boyko Borisov , Borisovi Co , First Faculty , French King , State Him , Sofia West , For Example , Was Not , Boykovo System , சோஃபியா கிரத் , ப்ரூக்ஸெல்ஸ் தலைநகரம் , முதல் ஆசிரிய , பிரஞ்சு கிங் , சோபியா மேற்கு , க்கு உதாரணமாக , இருந்தது இல்லை ,

PragueMED to Support New Medical Students in the Czech Republic

PragueMED to Support New Medical Students in the Czech Republic
praguemorning.cz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from praguemorning.cz Daily Mail and Mail on Sunday newspapers.

Czech Republic , United Kingdom , Zain Awan , Praguemed Ltd , Charles University , First Faculty , செக் குடியரசு , ஒன்றுபட்டது கிஂக்டம் , ஸேந் அவன் , சார்லஸ் பல்கலைக்கழகம் , முதல் ஆசிரிய ,

Telix Pharmaceuticals Limited: Czech Republic First European Country to Grant National Authorisation for the Use of Telix's Prostate Cancer Imaging Product

MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') announces today that the Ministry of Health of the Czech Republic ....

United States , New Zealand , Czech Republic , Stewart Holmstrom , David Zogala , Christian Behrenbruch , Telix Pharmaceuticals , Czech Ministry Of Health , Nuclear Medicine Institute , University Hospital Prague , Czech Society Of Nuclear Medicine , Treatment Programme , European Union , Corporate Communications , Telix Pharmaceuticals Limited , Ministry Of Health The Czech Republic , Therapeutic Goods Administration , Therapeutic Programme , Pharmaceuticals Limited , Prostate Specific Membrane Antigen , Positron Emission Tomography , Specific Therapeutic Programme , Czech Society , Nuclear Medicine , General University Hospital Prague , First Faculty ,

Czech Republic First European Country to Grant National Authorisation for the Use of Telix's Prostate Cancer Imaging Product

> Nachricht
Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
Nachrichtenquelle: globenewswire
| 16.02.2021, 07:05 |
163
|
0
MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the Ministry of Health of the Czech
Republic is the first European health authority to grant a national authorisation allowing the use of TLX591-CDx (Kit for the preparation of
68Ga-PSMA-11), a radiopharmaceutical
targeting Prostate-Specific Membrane Antigen (PSMA) for the imaging of prostate cancer using Positron Emission Tomography (PET).
The national authorisation, which is specific to Telix’s prostate cancer imaging prod ....

United States , New Zealand , Czech Republic , Stewart Holmstrom , David Zogala , Christian Behrenbruch , Abouttelix Pharmaceuticals , Telix Pharmaceuticals , Czech Ministry Of Health , Nuclear Medicine Institute , University Hospital Prague , Australian Securities Exchange , Czech Society Of Nuclear Medicine , Treatment Programme , European Union , Corporate Communications , Therapeutic Goods Administration , Czech Society , Nuclear Medicine , General University , Hospital Prague , First Faculty , Charles University Prague , Specific Treatment Programme , Molecularly Targeted Radiation , Priority Review ,

Czech Republic First European Country to Grant National Authorisation for the Use of Telix's Prostate Cancer Imaging Product Australian Stock Exchange:TLX.AX

Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
February 16, 2021 01:05 ET
| Source:
Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited
North Melbourne, AUSTRALIA
MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the Ministry of Health of the Czech Republic is the first European health authority to grant a national authorisation allowing the use of TLX591-CDx (Kit for the preparation of
68Ga-PSMA-11), a radiopharmaceutical targeting Prostate-Specific Membrane Antigen (PSMA) for the imaging of prostate cancer using Positron Emission Tomography (PET). ....

United States , New Zealand , Czech Republic , Stewart Holmstrom , David Zogala , Christian Behrenbruch , Telix Pharmaceuticals , Czech Ministry Of Health , Nuclear Medicine Institute , University Hospital Prague , Australian Securities Exchange , Czech Society Of Nuclear Medicine , Treatment Programme , European Union , Corporate Communications , Telix Pharmaceuticals Limited , Ministry Of Health The Czech Republic , Therapeutic Goods Administration , Therapeutic Programme , Pharmaceuticals Limited , Prostate Specific Membrane Antigen , Positron Emission Tomography , Specific Therapeutic Programme , Czech Society , Nuclear Medicine , General University Hospital Prague ,